Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.19.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Operating activities:    
Net income $ 580 $ 796
Adjustments to reconcile net income to net cash provided (used) by operating activities:    
Depreciation and amortization 811 533
Amortization of debt discount 14 5
Provision for bad debt expense 52 57
Non-cash lease expense 19
Share-based compensation 453 414
Inventory reserve 53 8
Provision for deferred income taxes 17 138
(Increase) decrease in operating assets:    
Accounts receivable 4,804 (5,620)
Inventories (1,892) (3,536)
Vendor deposits (283) (132)
Contract assets 2,156 369
Other assets (538) (584)
Increase (decrease) in operating liabilities:    
Accounts payable and accrued expenses (4,301) 2,550
Accrued employee expenses (1,069) (1,836)
Customer deposits 1,415 322
Contract liabilities (458) 654
Net cash provided (used) by operating activities 1,833 (5,862)
Investing activities:    
Capital expenditures (1,286) (647)
Cash paid for acquisitions, net of cash acquired (324) (4,294)
Net cash used by investing activities (1,610) (4,941)
Financing activities:    
Proceeds from borrowings 2,000 21,921
Debt repayments (2,000) (10,571)
Net cash provided by financing activities 11,350
Net increase in cash and cash equivalents 223 547
Cash and cash equivalents at beginning of period 5,038 1,330
Cash and cash equivalents at end of period 5,261 1,877
Supplemental disclosures of cash flow information:    
Cash paid during the period for interest 457 138
Cash paid during the period for income taxes 179 377
Supplemental disclosure of non-cash financing activities    
Common stock issued for acquisitions $ 1,294 $ 10,382